Krystal Biotech buy Citigroup Inc.
Start price
12.01.26
/
50%
€233.70
Target price
12.01.27
€288.19
Performance (%)
29.87%
Price
18.06.26
€303.50
Summary
This prediction is currently active. The prediction currently has a performance of 29.87%. This prediction currently runs until 12.01.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | 9.251% | 9.251% |
| iShares Core DAX® | 1.750% | 2.660% |
| iShares Nasdaq 100 | 4.301% | 6.593% |
| iShares Nikkei 225® | 9.895% | 18.278% |
| iShares S&P 500 | 2.542% | 3.062% |
Comments by Citigroup_Inc_ for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech (NASDAQ:KRYS) had its price target raised by analysts at Citigroup Inc. from $320.00 to $336.00. They now have a "buy" rating on the stock.
Ratings data for KRYS provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€152.00
27.02.24
27.02.24
€179.60
27.02.25
27.02.25
14.14%
28.02.25
28.02.25
